Title | Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Clement CC, Nanaware PP, Yamazaki T, Negroni MPia, Ramesh K, Morozova K, Thangaswamy S, Graves A, Kim HJung, Li TWanxia, Vigano' M, Soni RK, Gadina M, Tse HY, Galluzzi L, Roche PA, Denzin LK, Stern LJ, Santambrogio L |
Journal | Immunity |
Volume | 54 |
Issue | 4 |
Pagination | 721-736.e10 |
Date Published | 2021 Apr 13 |
ISSN | 1097-4180 |
Keywords | Animals, Antigen Presentation, Antigen-Presenting Cells, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Disease Models, Animal, Epitopes, Female, Histocompatibility Antigens Class II, Male, Mice, Mice, Inbred C57BL, Peptides, Protein Binding, Stress, Physiological |
Abstract | Hyperglycemia and hyperlipidemia are often observed in individuals with type II diabetes (T2D) and related mouse models. One dysmetabolic biochemical consequence is the non-enzymatic reaction between sugars, lipids, and proteins, favoring protein glycation, glycoxidation, and lipoxidation. Here, we identified oxidative alterations in key components of the major histocompatibility complex (MHC) class II molecule antigen processing and presentation machinery in vivo under conditions of hyperglycemia-induced metabolic stress. These modifications were linked to epitope-specific changes in endosomal processing efficiency, MHC class II-peptide binding, and DM editing activity. Moreover, we observed some quantitative and qualitative changes in the MHC class II immunopeptidome of Ob/Ob mice on a high-fat diet compared with controls, including changes in the presentation of an apolipoprotein B100 peptide associated previously with T2D and metabolic syndrome-related clinical complications. These findings highlight a link between glycation reactions and altered MHC class II antigen presentation that may contribute to T2D complications. |
DOI | 10.1016/j.immuni.2021.02.019 |
Alternate Journal | Immunity |
PubMed ID | 33725478 |
PubMed Central ID | PMC8046741 |
Grant List | P01 AG031782 / AG / NIA NIH HHS / United States R01 AI117535 / AI / NIAID NIH HHS / United States R01 AI137198 / AI / NIAID NIH HHS / United States R01 AI146180 / AI / NIAID NIH HHS / United States |